UK – Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal
More from BrexitMore posts in Brexit »
- UK – Medicines and Medical Devices Bill: overarching documents
- Ireland – HPRA update – Brexit Transitional Period: Implications for Medicine and Medical Device Companies up to 31 December 2020
- From RAPS – UK Introduces Medicines, Medical Devices Bill in Post-Brexit Overhaul
- UK – Future of UK Life Sciences: how to reshape the industry for the 2020s (from The Economist)
- Update from GOV.UK – Regulating medical devices in the event of a no-deal Brexit – UK Responsible Person
More from UKMore posts in UK »
- UK – MHRA – Medical Device “Certificates of Compliance” / “Attestation of Conformity” have no legal standing under MDR
- UK – Independent Medicines and Medical Devices Safety Review report and MHRA response
- UK – MHRA – Effective field safety notices (FSNs): guidance for manufacturers of medical devices
- UK – Medicines and Medical Devices Bill: overarching documents
- Ireland – HPRA update – Brexit Transitional Period: Implications for Medicine and Medical Device Companies up to 31 December 2020
Be First to Comment